Last news
iNtRON has confirmed the efficacy of BAL200, a novel endolysin biologic for Inhalational Anthrax

iNtRON has confirmed the efficacy of BAL200, a novel endolysin biologic for Inhalational Anthrax

...

IMAX China Reports Second Highest CNY Four-Day IMAX box office total of RMB 161 million

IMAX China Reports Second Highest CNY Four-Day IMAX box office total of RMB 161 million

...

Pack Light & Stay Motivated: Westin Hotels & Resorts Launches a Refueled Gear Lending Program

Pack Light & Stay Motivated: Westin Hotels & Resorts Launches a Refueled Gear Lending Program

...

Brankas introduces advanced fraud detection in its Open Finance solutions through new strategic partnership with Element

Brankas introduces advanced fraud detection in its Open Finance solutions through new strategic partnership with Element

...

HBM Alpha Therapeutics Raises Seed Round to Advance Next-Gen Therapies for Endocrine Disorders

HBM Alpha Therapeutics Raises Seed Round to Advance Next-Gen Therapies for Endocrine Disorders

...

Daewoong Pharmaceutical submitted NDA for its global new drug Fexuclue in 11 countries, only 1 year after approval in Korea

Daewoong Pharmaceutical submitted NDA for its global new drug Fexuclue in 11 countries, only 1 year after approval in Korea

...

GenKOre Announces Collaboration with a US-based Company on In vivo Gene-editing Therapy

GenKOre Announces Collaboration with a US-based Company on In vivo Gene-editing Therapy

...

ReLive Biotechnologies, Ltd. Completes Asset Purchase of Co.Don AG and Series A Financing Led By SHC, Furthering its Ambition to Become the Global Leader in Regenerative Therapies

ReLive Biotechnologies, Ltd. Completes Asset Purchase of Co.Don AG and Series A Financing Led By SHC, Furthering its Ambition to Become the Global Leader in Regenerative Therapies

...

menu
menu